^Kannattaa huomata, että yli sadassa kliinisessä tutkimuksessa pätkäpaastoilun (aikarajoitetun syömisen tyylillä) on havaittu tuottavan myönteisiä terveysvaikutuksia, suurempia tai pienempiä. Yhdessäkään ei ole havaittu mitään sen kaltaista hälyyttävää haittavaikutusta, jollaisella tämä surkea alkeellisia virheitä sisältävä korrelaatio"tutkimus" yrittää pelotella.
Sydänliittomme amerikkalaisen sisarjärjestön AHA:n uskottavuudesta ei tämän propagandaiskun jälkeen ole paljoa jäljellä. Se alkaa IMHO olla olla taas samalla tasolla kuin silloin kun Procter & Gamblelta runsaasti rahoitusta saanut AHA teki hervotonta propagandaa epäterveelisen leivontarasvan Criscon puolesta.
Lainaa:
In contrast to the conclusion of this study, over 100 published peer-reviewed clinical trials
have reported that TRE has small to large metabolic health benefits, or little effects, but no
study observed serious adverse health outcomes of TRE. Meta-analyses of clinical trials show
that TRE reduces body weight and improves blood pressure [4, 5]. Moreover, multiple studies in
animals show that TRE extends lifespan [6,7].
Dissemination of alarming headlines about findings without rigorous peer-review is dangerous to
public health, healthcare messaging, trust in the scientific community, and ongoing clinical trials.
We urge all scientific communities to support responsible and careful communication of
study findings and ensure the thorough peer-review of the complete study methods, data,
results, and conclusions. Not doing so can lead to misleading and over-dramatized media
coverage and long-term damage to the field.
AHA:lle murhaavan analyysin allekirjoittaneet tutkijat ovat pätkäpaasatoilun asiantuntijoita:
34 experts in time-restricted eating, intermittent fasting, temporal eating patterns, clinical trials,
and epidemiological methods
Emily Manoogian, Ph.D., Salk Institute for Biological Studies
Courtney Peterson, Ph.D., University of Alabama
Mary Playdon, Ph.D., MPH, University of Utah
Krista Varady, Ph.D., University of Illinois Chicago
Kelsey Gabel, PhD., University of Illinois Chicago
Leonie Heilbron, Ph.D., University of Adelaide
Michael Wilkinson, M.D., University of California San Diego Medical School
Tinh-Hai Collet, M.D., University of Geneva
Rafael de Cabo, Ph.D., National Institutes of Health, National Institute on Aging
Dorothy D Sears, Ph.D., Arizona State University
Julie Pendergast, Ph.D., University of Kentucky
Eric Ravussin, Ph.D., Pennington Biomedical Research Center
Amber Kleckner, Ph.D., University of Maryland
John Hawley, Ph.D., Australian Catholic University
Evelyn Parr, Ph.D., Australian Catholic University
Jonas Salling Quist, Ph.D., Steno Diabetes Center Copenhagen
Anne-Ditte Termannsen, MSc, Steno Diabetes Center Copenhagen
Kristine Faerch, Ph.D., Novo Nordisk A/S
Sheri L. Johnson, Ph.D. University of California Berkeley
Omar Mesarwi, M.D., University of California San Diego Medical School
Paula Desplats, Ph.D., University of California San Diego
John Hogenesh, Ph.D., Cincinnati Children’s Hospital Medical Center
Charna Dibner, Ph.D., University of Geneva
Dara L. James, Ph.D., MS, Arizona State University
Catherine Marinac, Ph.D., Harvard Medical School, Dana Farber Cancer Institute
Iwona Swiatkiewicz, M.D., Ph.D., University of California San Diego
Adriana Coletta, Ph.D., MS, RD, University of Utah
Sheetal Hardikar, Ph.D., MBBS, MPH, University of Utah
Amandine Chaix, Ph.D., University of Utah
Blandine Laferrère, M.D., Columbia University Irving Medical Center
Lisa Chow, M.D. MS, University of Minnesota
Phyllis Zee, M.D., Ph.D. Northwestern University Feinberg School of Medicine
Rekisteröidy
Kirjaudu sisään
UKK
Etsi
